Literature DB >> 20166953

Calpains: attractive targets for the development of synthetic inhibitors.

Markus Pietsch1, Krystle C H Chua, Andrew D Abell.   

Abstract

The physiological roles of calpains are discussed, as are the associated pathological disorders that result from their over-activation. We also present practical information for establishing functional inhibition assays and an overview of X-ray crystal structures of calpain-inhibitor complexes to aid inhibitor design. These structures reveal the expected extended beta-strand conformation for the inhibitor backbone, a geometry that has been engineered into inhibitors with the introduction of either an N-terminal heterocycle or a macrocycle that links the P(1) and P(3) residues. The structure and function of all the main classes of inhibitors are reviewed, with most examples being classified according to the nature of the C-terminal reactive warhead group that reacts with the active site cysteine of calpains. These inhibitor classes include epoxysuccinate derivatives, aldehydes, aldehyde prodrugs (hemiacetals) and alpha-keto carbonyl compounds. Inhibitors derived from the endogenous inhibitor calpastatin and examples lacking a warhead, are now known and these are also discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166953     DOI: 10.2174/156802610790725489

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  21 in total

1.  Inhibitors of polyhydroxyalkanoate (PHA) synthases: synthesis, molecular docking, and implications.

Authors:  Wei Zhang; Chao Chen; Ruikai Cao; Leila Maurmann; Ping Li
Journal:  Chembiochem       Date:  2014-11-13       Impact factor: 3.164

2.  Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.

Authors:  Isaac T Schiefer; Subhasish Tapadar; Vladislav Litosh; Marton Siklos; Rob Scism; Gihani T Wijewickrama; Esala P Chandrasena; Vaishali Sinha; Ehsan Tavassoli; Michael Brunsteiner; Mauro Fa'; Ottavio Arancio; Pavel Petukhov; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2013-07-22       Impact factor: 7.446

Review 3.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

4.  Development of α-helical calpain probes by mimicking a natural protein-protein interaction.

Authors:  Hyunil Jo; Nataline Meinhardt; Yibing Wu; Swapnil Kulkarni; Xiaozhen Hu; Kristin E Low; Peter L Davies; William F DeGrado; Doron C Greenbaum
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

5.  Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration.

Authors:  Marek Ma; Toby A Ferguson; Kathleen M Schoch; Jian Li; Yaping Qian; Frances S Shofer; Kathryn E Saatman; Robert W Neumar
Journal:  Neurobiol Dis       Date:  2013-03-28       Impact factor: 5.996

6.  Attenuation of Blood-Brain Barrier Breakdown and Hyperpermeability by Calpain Inhibition.

Authors:  Himakarnika Alluri; Marcene Grimsley; Chinchusha Anasooya Shaji; Kevin Paul Varghese; Shenyuan L Zhang; Chander Peddaboina; Bobby Robinson; Madhava R Beeram; Jason H Huang; Binu Tharakan
Journal:  J Biol Chem       Date:  2016-11-08       Impact factor: 5.157

7.  Selenoprotein K is a novel target of m-calpain, and cleavage is regulated by Toll-like receptor-induced calpastatin in macrophages.

Authors:  Zhi Huang; Fukun W Hoffmann; Robert L Norton; Ann C Hashimoto; Peter R Hoffmann
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

8.  The Toxic Effect of ALLN on Primary Rat Retinal Neurons.

Authors:  Na Li; Lei Shang; Shu-Chao Wang; Lv-Shuang Liao; Dan Chen; Ju-Fang Huang; Kun Xiong
Journal:  Neurotox Res       Date:  2016-05-19       Impact factor: 3.911

Review 9.  Role of calpains in the injury-induced dysfunction and degeneration of the mammalian axon.

Authors:  Marek Ma
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

10.  Calpastatin prevents NF-κB-mediated hyperactivation of macrophages and attenuates colitis.

Authors:  Zhi Huang; Aaron H Rose; FuKun W Hoffmann; Ann S Hashimoto; Pietro Bertino; Tobias Denk; Jiro Takano; Nobuhisa Iwata; Takaomi C Saido; Peter R Hoffmann
Journal:  J Immunol       Date:  2013-08-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.